Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.26525
-0.0121 (-4.38%)
Sep 28, 2026, 12:17 PM EDT - Market open
Scienture Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 0.82 | 0.43 | 0.14 | 1.36 | 0.3 | |
Revenue Growth | 540.64% | 215.87% | -89.98% | 354.61% | - |
Cost of Revenue | 0.1 | 0.1 | 0.13 | 1.31 | - |
Gross Profit | 0.72 | 0.33 | 0.01 | 0.05 | 0.3 |
Selling, General & Admin | 11.95 | 14.62 | 12.47 | 4.45 | 0.88 |
Research & Development | 2.5 | 1.96 | 2.24 | - | 3.06 |
Operating Expenses | 14.45 | 16.58 | 14.71 | 4.45 | 3.94 |
Operating Income | -13.72 | -16.24 | -14.7 | -4.4 | -3.64 |
Interest Expense | -3.07 | -4.08 | -1.34 | -1.14 | -0.08 |
Interest & Investment Income | 0.49 | 0.3 | 0.14 | 0 | - |
Other Non Operating Income (Expenses) | 2.55 | 3.21 | -0 | -0.15 | 0.01 |
EBT Excluding Unusual Items | -13.74 | -16.82 | -15.9 | -5.68 | -3.71 |
Impairment of Goodwill | -21.37 | -21.37 | - | - | - |
Gain (Loss) on Sale of Investments | - | - | -2.5 | - | - |
Gain (Loss) on Sale of Assets | 0.1 | -0.29 | -0.37 | -2.8 | - |
Asset Writedown | -4.97 | -4.97 | - | - | - |
Other Unusual Items | 0.04 | -0.05 | - | - | - |
Pretax Income | -39.95 | -43.51 | -18.78 | -8.48 | -3.71 |
Income Tax Expense | -1.99 | -1.99 | -0.53 | - | - |
Earnings From Continuing Operations | -37.95 | -41.51 | -18.24 | -8.48 | -3.71 |
Earnings From Discontinued Operations | - | - | 27.31 | -9.36 | - |
Net Income | -37.95 | -41.51 | 9.07 | -17.84 | -3.71 |
Net Income to Common | -37.95 | -41.51 | 9.07 | -17.84 | -3.71 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 29 | 15 | 3 | 1 | 5 |
Shares Outstanding (Diluted) | 29 | 15 | 3 | 1 | 5 |
Shares Change | 236.59% | 354.69% | 341.76% | -84.72% | - |
EPS (Basic) | -1.30 | -2.70 | 2.69 | -23.35 | -0.74 |
EPS (Diluted) | -1.30 | -2.70 | 2.68 | -23.35 | -0.74 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -14.44 | -13.38 | -14.28 | -2.23 | -3.35 |
Free Cash Flow Per Share | -0.49 | -0.87 | -4.23 | -2.91 | -0.67 |
Gross Margin | 87.72% | 76.80% | 4.40% | 3.60% | 100.00% |
Operating Margin | -1671.08% | -3763.77% | -10758.70% | -322.36% | -1213.87% |
Profit Margin | -4620.92% | -9618.03% | 6634.66% | -1308.34% | -1236.13% |
Free Cash Flow Margin | -1758.23% | -3099.95% | -10448.57% | -163.16% | -1117.56% |
EBITDA | -12.36 | -15.79 | -14.7 | -3.56 | - |
EBITDA Margin | - | - | - | -261.20% | - |
D&A For EBITDA | 1.36 | 0.46 | 0 | 0.83 | - |
EBIT | -13.72 | -16.24 | -14.7 | -4.4 | -3.64 |